Results 251 to 260 of about 1,151,684 (305)
Correction: Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma. [PDF]
OncotargetCho N, Ko S, Shokeen M.
europepmc +1 more source
Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy. [PDF]
Int J NanomedicineShan L +9 more
europepmc +1 more source
Tumor-targeting nanomaterials based on metal-organic frameworks mediate tumor immunotherapy by promoting cuproptosis and pyroptosis in hepatocellular carcinoma cells. [PDF]
Mater Today BioYi X +9 more
europepmc +1 more source
An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting. [PDF]
Mol Ther OncolWienen F +6 more
europepmc +1 more source
Protocol for constructing tumor-targeting ANM-PROTACs for degradation of transcription factors. [PDF]
STAR ProtocLi J, Liang C.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Tumor vasculature-targeting nanomedicines
Acta Biomaterialia, 2021Uncontrolled tumor growth and subsequent distant metastasis are highly dependent on an adequate nutrient supply from tumor blood vessels, which have relatively different pathophysiological characteristics from those of normal vasculature. Obviously, strategies targeting tumor vasculature, such as anti-angiogenic drugs and vascular disrupting agents ...
Ying, Zhang, Jingni, He
openaire +2 more sources
Targeting the Tumor-Tumor Microenvironment Crosstalk
Expert Opinion on Therapeutic Targets, 2023Cancer development and progression is a complex process influenced by co-evolution of the cancer cells and their microenvironment. However, traditional anti-cancer therapy is mostly targeted toward cancer cells. To improve the efficacy of cancer drugs, the complex interactions between the tumor (T) and the tumor microenvironment (TME) should be ...
Sunil S. Badve, Yesim Gökmen-Polar
openaire +2 more sources
Current Opinion in Cell Biology, 2003
Several recent scientific and technical developments have made it possible to postulate the use of the 'magic bullet' concept; that is, the identification of specific antigens present on tumor cells that can be targeted either by therapeutic antibodies or by small molecules.
Pantea, Houshmand, Albert, Zlotnik
openaire +2 more sources
Several recent scientific and technical developments have made it possible to postulate the use of the 'magic bullet' concept; that is, the identification of specific antigens present on tumor cells that can be targeted either by therapeutic antibodies or by small molecules.
Pantea, Houshmand, Albert, Zlotnik
openaire +2 more sources
Seminars in Oncology, 2009
Our understanding of the process of tumor angiogenesis has changed significantly since the late 1970s, when vascular endothelial growth factor (VEGF) was first identified as vascular permeability factor and later found to be the major mediator of physiologic and pathologic angiogenesis.
Puja, Gaur +3 more
openaire +2 more sources
Our understanding of the process of tumor angiogenesis has changed significantly since the late 1970s, when vascular endothelial growth factor (VEGF) was first identified as vascular permeability factor and later found to be the major mediator of physiologic and pathologic angiogenesis.
Puja, Gaur +3 more
openaire +2 more sources
2013
Four decades after the seminal work of Judah Folkman, in 1971, cancer therapies based on the suppression of neo-angiogenesis (Folkman, N Engl J Med 285:1182–1186, 1971) are becoming a reality (Verheul et al., Clin Cancer Res 14(11):3589–3597, 2008).
STAIBANO, STEFANIA +1 more
openaire +2 more sources
Four decades after the seminal work of Judah Folkman, in 1971, cancer therapies based on the suppression of neo-angiogenesis (Folkman, N Engl J Med 285:1182–1186, 1971) are becoming a reality (Verheul et al., Clin Cancer Res 14(11):3589–3597, 2008).
STAIBANO, STEFANIA +1 more
openaire +2 more sources